Herr Investment Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,000
Closed -$47.8K 82
2024
Q1
$47.8K Buy
+10,000
New +$46.4K 0.01% 72
2023
Q1
Sell
-1,403,578
Closed -$14.4M 83
2022
Q4
$14.4M Buy
+1,403,578
New +$24.8M 0.88% 22

Other funds holding NVAX

Herr Investment Group's NVAX Position: Q2 2024 in Review

Herr Investment Group sold out of Novavax (NVAX) in Q2 2024, closing a stake of 10,000 shares — an estimated $47.8K sold.

Herr Investment Group first reported a position in NVAX in Q4 2022 and held it in 2 quarters. The position peaked at $14.4M in Q4 2022. 230 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.

  • Herr Investment Group reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
  • Herr Investment Group sold 10,000 Novavax shares in Q2 2024, an estimated $47.8K.
  • Herr Investment Group first reported a position in Novavax in Q4 2022 and held it in 2 quarters.
  • Herr Investment Group's Novavax position peaked at $14.4M in Q4 2022.
  • 230 funds tracked by Wall St. Rank held Novavax as of Q2 2024.

Based on Herr Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.